Viva Biotech Holdings ( (HK:1873) ) has issued an update.
Viva Biotech Holdings announced that its board of directors will meet on March 27, 2025, to consider and approve the company’s annual results for the year ended December 31, 2024. The board will also discuss the potential recommendation for a final dividend, highlighting the company’s ongoing financial management and strategic planning.
More about Viva Biotech Holdings
Viva Biotech Holdings is a company incorporated in the Cayman Islands, operating in the biotech industry. It focuses on providing services and products related to biotechnology research and development.
YTD Price Performance: 97.67%
Average Trading Volume: 6,044,198
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$3.65B
Learn more about 1873 stock on TipRanks’ Stock Analysis page.